Sutro Biopharma STRO Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on trailing twelve months.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's operating margin?
- Sutro Biopharma (STRO) reported operating margin of -120% in Q1 2026.
- How has Sutro Biopharma's operating margin changed year-over-year?
- Sutro Biopharma's operating margin increased by 68.2% year-over-year, from -376.9% to -120%.
- What is the long-term trend for Sutro Biopharma's operating margin?
- Over 4 years (2020 to 2025), Sutro Biopharma's operating margin has grown at a -1.8% compound annual growth rate (CAGR), from -166.3% to -154.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.